Home hover Guidelines hover Expert hover Compare hover Faq hover Submit hover About hover Resources hover Syntheses hover Myngc hover Guidelinematrix hover
Home
Browse Guidelines
Expert Commentaries
Guideline Syntheses
Guideline Matrix
Guideline Resources
Compare Guidelines
Frequently Asked Questions
Submit Guidelines
About
myNGC
Search within:  

Sort results by:      



Filter results by:

1-20 of 54   Next >
 
1.  
Alemtuzumab for treating relapsing–remitting multiple sclerosis. 2014 May. NGC:010430
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
2.  
Teriflunomide for treating relapsing–remitting multiple sclerosis. 2014 Jan. NGC:010284
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
3.  
Dimethyl fumarate for treating relapsing-remitting multiple sclerosis. 2014 Aug. NGC:010519
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
4.  
Fingolimod for the treatment of highly active relapsing-remitting multiple sclerosis. 2012 Apr. NGC:009075
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
6.  
Recommendations for drug therapies for relapsing-remitting multiple sclerosis. 2013 Oct. NGC:010418
Canadian Agency for Drugs and Technologies in Health - Nonprofit Organization. View all guidelines by the developer(s)
8.  
Use of imaging in multiple sclerosis. 2006 Apr (revised 2011). NGC:008784
European Academy of Neurology - Medical Specialty Society. View all guidelines by the developer(s)
9.  
Nursing management of the patient with multiple sclerosis. 2011. NGC:009286
American Association of Neuroscience Nurses - Professional Association; Association of Rehabilitation Nurses - Professional Association; International Organization of Multiple Sclerosis Nurses - Professional Association. View all guidelines by the developer(s)
10.  
Multiple sclerosis: management of multiple sclerosis in primary and secondary care. 2004 (revised 2014 Oct). NGC:010569
National Clinical Guideline Centre - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
12.  
Occupational therapy practice guidelines for adults with neurodegenerative diseases. 2014. NGC:010522
American Occupational Therapy Association, Inc. - Professional Association. View all guidelines by the developer(s)
18.  
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. 2006 Nov (revised 2010 Sep). NGC:008162
European Academy of Neurology - Medical Specialty Society. View all guidelines by the developer(s)
19.  
Routine cerebrospinal fluid (CSF) analysis. 2006 Sep (revised 2011). NGC:008781
European Academy of Neurology - Medical Specialty Society. View all guidelines by the developer(s)
20.  
1-20 of 54   Next >